Related Experiment Video
Updated: Jun 24, 2025

04:41
Mapping Alzheimer's Disease Variants to Their Target Genes Using Computational Analysis of Chromatin Configuration
Published on: January 9, 2020
19.0K
A single-cell and spatial RNA-seq database for Alzheimer's disease (ssREAD).
Cankun Wang1, Diana Acosta2, Megan McNutt1
1Department of Biomedical Informatics, The Ohio State University, Columbus, OH, 43210, USA.
Nature Communications
|June 6, 2024
Summary
Alzheimer's Disease research now has a comprehensive database, ssREAD, integrating single-cell and spatial transcriptomics data. This resource aids in understanding complex brain changes and identifying potential therapeutic targets.
Area of Science:
- Neuroscience
- Genomics
- Bioinformatics
Background:
- Alzheimer's Disease (AD) research increasingly utilizes single-cell and spatial transcriptomics (scRNA-seq, snRNA-seq, ST) to unravel complex pathology.
- A significant challenge is the lack of a centralized, user-friendly repository for this rapidly growing volume of data.
Purpose of the Study:
- To introduce ssREAD, a novel database consolidating diverse single-cell and spatial RNA sequencing datasets for Alzheimer's Disease research.
- To provide an optimized analytical pipeline and enhanced usability for researchers studying AD at a cellular and spatial level.
Main Methods:
- Aggregated 1,053 samples (277 datasets) from 67 scRNA-seq/snRNA-seq studies and 381 ST datasets from 18 human and mouse brain studies.
- Annotated datasets with critical metadata including species, gender, brain region, disease status, age, and AD Braak stages.
- Developed an integrated analysis suite for tasks like cell clustering, differential gene expression, and spatial analysis.
Main Results:
- The ssREAD database contains 7,332,202 cells from scRNA-seq/snRNA-seq studies and numerous spatial transcriptomics datasets.
- Comprehensive annotations facilitate detailed comparative analyses across different studies and conditions.
- The analysis suite enables advanced exploration of cell-type-specific markers, gene regulation, and spatial patterns in AD.
Conclusions:
- ssREAD offers a valuable, freely accessible resource for the Alzheimer's Disease research community.
- The database and its analytical tools empower deeper insights into AD pathogenesis through multi-omic data integration.
- Facilitates discovery of novel biomarkers and therapeutic strategies for Alzheimer's Disease.
More Related Videos
Related Concept Videos
RNA-seq
9.9K
RNA sequencing, or RNA-Seq, is a high-throughput sequencing technology used to study the transcriptome of a cell. Transcriptomics helps to interpret the functional elements of a genome and identify the molecular constituents of an organism. Additionally, it also helps in understanding the development of an organism and the occurrence of diseases.
Before the discovery of RNA-seq, microarray-based methods and Sanger sequencing were used for transcriptome analysis. However, while...
Before the discovery of RNA-seq, microarray-based methods and Sanger sequencing were used for transcriptome analysis. However, while...
9.9K
Alzheimer's Disease: Overview
462
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
462

